Overview

Osseo Imaging will truly revolutionize both the orthopedic medicine and dental imaging markets through the introduction of novel imaging device solutions . These solutions will significantly advance the “gold standard” of medical and dental imaging, modeling, and diagnostics. No existing solution provides unified soft and hard tissue imaging, first-ever 3-D bone mineral density (BMD) measurements, and “true” “to-scale” 3-D replication of entire anatomical structures, especially in a clinically affordable and maintainable device. When multiple images from other technologies are used in combination to visualize both soft and hard tissues, such as MRI and X-ray, subjective comparison and interpretation between the images increases error, and therefore failure rates and the likelihood for sepsis infection. Both medical and dental practitioners will profit from more in-house imaging, higher resolution 3-D image quality leading to better “pay for performance” success rates, simplicity, and speed. Patients will also value better procedural comfort and convenience due to less visits and separate co-pays with multiple imaging methodologies. Both will be less concerned with much lower x-ray dosage and required shielding. Research institutes, hospitals, and scan centers will appreciate all these benefits in higher resolution and functionality models designed for more demanding needs. The company’s solutions can be used around metal, and do not require invasive radioactive contrast mediums, patient immobility, specific patient positioning, nor suffers from 3-D to 2-D superimposition artifacts, scatter, or angular distortion. "Dual Energy X-Ray Absorptiometry and 3-D Tomosynthesis" technology is proprietary, patented, and 100% controlled by the company.